Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Device-Like System Proposed For Low-Risk Human Cell Therapies, Tissue-Based Products At US FDA
Mar 25 2025
•
By
Kate Rawson
The FDA wants to revamp its current regulatory framework for human cell and tissue-based therapies.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Cell & Gene Therapies
More from Pathways & Standards